Literature DB >> 21502797

Early hypertension and prolonged mineralocorticoid therapy discontinuation in a child with salt-wasting 21-hydroxylase deficiency.

M Wasniewska, M Valenzise, T Aversa, S Mirabelli, F De Luca, F L De Luca, F Lombardo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21502797     DOI： 10.1007/BF03347048

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  16 in total

1.  Developmental expression of human hepatic CYP2C9 and CYP2C19.

Authors:  Sevasti B Koukouritaki; Jason R Manro; Sandra A Marsh; Jeffrey C Stevens; Allan E Rettie; D Gail McCarver; Ronald N Hines
Journal:  J Pharmacol Exp Ther       Date:  2003-11-21       Impact factor: 4.030

Review 2.  Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology.

Authors: 
Journal:  J Clin Endocrinol Metab       Date:  2002-09       Impact factor: 5.958

3.  In Sicilian ethnic group non-classical congenital adrenal hyperplasia is frequently associated with a very mild genotype.

Authors:  M Wasniewska; G Di Pasquale; I Rulli; G Salzano; M Caruso; S Indovina; L Di Pasquale; G Zirilli; F De Luca
Journal:  J Endocrinol Invest       Date:  2007-03       Impact factor: 4.256

Review 4.  Mineralocorticoid hypertension.

Authors:  P M Stewart
Journal:  Lancet       Date:  1999-04-17       Impact factor: 79.321

5.  Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr).

Authors:  E Cacciari; S Milani; A Balsamo; E Spada; G Bona; L Cavallo; F Cerutti; L Gargantini; N Greggio; G Tonini; A Cicognani
Journal:  J Endocrinol Invest       Date:  2006 Jul-Aug       Impact factor: 4.256

6.  Altered 24-hour blood pressure profiles in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Thomas M K Völkl; Diemud Simm; Jörg Dötsch; Wolfgang Rascher; Helmuth G Dörr
Journal:  J Clin Endocrinol Metab       Date:  2006-09-26       Impact factor: 5.958

7.  Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency.

Authors:  Larissa G Gomes; Ningwu Huang; Vishal Agrawal; Berenice B Mendonça; Tania A S S Bachega; Walter L Miller
Journal:  J Clin Endocrinol Metab       Date:  2008-10-28       Impact factor: 5.958

8.  The relationship of body mass index and blood pressure in primary care pediatric patients.

Authors:  Bonita Falkner; Samuel S Gidding; Gabriela Ramirez-Garnica; Stacey Armatti Wiltrout; David West; Elizabeth B Rappaport
Journal:  J Pediatr       Date:  2006-02       Impact factor: 4.406

9.  Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report.

Authors:  Edna F Roche; Evangelia Charmandari; Mehul T Dattani; Peter C Hindmarsh
Journal:  Clin Endocrinol (Oxf)       Date:  2003-05       Impact factor: 3.478

10.  Observation of hypertension in children with 21-hydroxylase deficiency: a preliminary report.

Authors:  Todd D Nebesio; Erica A Eugster
Journal:  Endocrine       Date:  2006-12       Impact factor: 3.925
View more
  1 in total

1.  Treatment of congenital adrenal hyperplasia in children aged 0-3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure.

Authors:  Uta Neumann; Annelieke van der Linde; Ruth E Krone; Nils P Krone; Ayla Güven; Tülay Güran; Heba Elsedfy; Sukran Poyrazoglu; Feyza Darendeliler; Tania A S S Bachega; Antonio Balsamo; Sabine E Hannema; Niels Birkebaek; Ana Vieites; Ajay Thankamony; Martine Cools; Tatjana Milenkovic; Walter Bonfig; Eduardo Correa Costa; Navoda Atapattu; Liat de Vries; Guilherme Guaragna-Filho; Marta Korbonits; Klaus Mohnike; Jillian Bryce; S Faisal Ahmed; Bernard Voet; Oliver Blankenstein; Hedi L Claahsen-van der Grinten
Journal:  Eur J Endocrinol       Date:  2022-04-11       Impact factor: 6.558
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.